Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Itakura

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Journal of Hepatology|August 21, 2003
Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimensYasuhiro Asahina, Namiki Izumi, Masakatsu Uchihara, et al.
Journal of Hepatology|December 4, 2003
Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype CYasuhiro Asahina, Namiki Izumi, Masakatsu Uchihara, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 16, 2014
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinomaKaoru Tsuchiya, Yasuhiro Asahina, Nobuharu Tamaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 5, 2005
[A case of advanced gastric cancer acquired long-term response two years or more by treatment with oral anticancer drug TS-1]Jun Itakura, Namiki Izumi, Kazunari Inoue, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 19, 2019
Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimenAtsunori Kusakabe, Masayuki Kurosaki, Jun Itakura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 4, 2004
Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosisJun Itakura, Namiki Izumi, Yuki Nishimura, et al.
Cancer Medicine|October 18, 2016
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinomaHitomi Takada, Kaoru Tsuchiya, Yutaka Yasui, et al.
Surgery Today|October 12, 2002
Surgical treatment of retroperitoneal leiomyosarcoma invading the inferior vena cava: report of three casesShunya Shindo, Harunobu Matsumoto, Kouji Ogata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 31, 2003
Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportographyYasuhiro Asahina, Namiki Izumi, Masakatsu Uchihara, et al.
Journal of Gastroenterology and Hepatology|August 18, 2005
Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapyKosei Hamano, Naoya Sakamoto, Nobuyuki Enomoto, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Journal of Hepatology|August 21, 2003
Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimensYasuhiro Asahina, Namiki Izumi, Masakatsu Uchihara, et al.
Journal of Hepatology|December 4, 2003
Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype CYasuhiro Asahina, Namiki Izumi, Masakatsu Uchihara, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 16, 2014
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinomaKaoru Tsuchiya, Yasuhiro Asahina, Nobuharu Tamaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 5, 2005
[A case of advanced gastric cancer acquired long-term response two years or more by treatment with oral anticancer drug TS-1]Jun Itakura, Namiki Izumi, Kazunari Inoue, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 19, 2019
Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimenAtsunori Kusakabe, Masayuki Kurosaki, Jun Itakura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 4, 2004
Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosisJun Itakura, Namiki Izumi, Yuki Nishimura, et al.
Cancer Medicine|October 18, 2016
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinomaHitomi Takada, Kaoru Tsuchiya, Yutaka Yasui, et al.
Surgery Today|October 12, 2002
Surgical treatment of retroperitoneal leiomyosarcoma invading the inferior vena cava: report of three casesShunya Shindo, Harunobu Matsumoto, Kouji Ogata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 31, 2003
Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportographyYasuhiro Asahina, Namiki Izumi, Masakatsu Uchihara, et al.
Journal of Gastroenterology and Hepatology|August 18, 2005
Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapyKosei Hamano, Naoya Sakamoto, Nobuyuki Enomoto, et al.
Pageof 13